Biotechopoly™ Antibody Edition

In Biotechopoly Antibody Edition, players move a potential product from pre-clinical research, to phase I studies, phase II/III studies, and to market. Whoever gets their product to market first, wins.

As players roll dice to move their company token around the board, they have to raise money, hire personnel, collect data, prepare documents, and pay their bills. Along the way, players experience luck and karma, take risks, and encounter the trials and tribulations of developing biotechnology products. Players have said that Biotechopoly is fun, educational, engaging and, full of surprises–both good and bad.

Acknowledgements: This work has been funded in part by NSF ATE grants (DUE 1764225 and DUE 2055036). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. We wish to thank the Antibody Engineers hackathon team (Dua Hassan, Frances Weis-Garcia, Feather Ives, Margaret Bryans) and Mike Jenkins for help with advancing basic game play and experimenting with online strategies. Students at Montgomery County Community College played early versions and provided important feedback. Aron Kamajaya, Sheela Vemu, Todd Smith, and Feather Ives led game sessions at the 2023 HI TEC conference. Roxanne Porter-Smith and Noah Havelaar helped with play testing and provided critical advice.